Health Care & Life Sciences » Pharmaceuticals | Hainan Shuangcheng Pharmaceuticals Co. Ltd.

Hainan Shuangcheng Pharmaceuticals Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
567
465
250
30
179
208
Total Accounts Receivable
17
23
95
47
241
76
Inventories
31
53
28
34
120
86
Other Current Assets
49
80
106
37
18
2
Total Current Assets
663
621
479
149
558
372
Net Property, Plant & Equipment
213
264
443
671
688
641
Total Investments and Advances
3
3
480
210
-
-
Intangible Assets
34
48
134
106
101
96
Other Assets
1
3
8
27
29
9
Total Assets
917
944
1,550
1,166
1,377
1,120
ST Debt & Current Portion LT Debt
-
2
348
193
46
Accounts Payable
11
7
10
26
80
Income Tax Payable
5
5
7
1
1
Other Current Liabilities
14
9
80
36
75
Total Current Liabilities
29
23
445
255
201
Long-Term Debt
-
-
145
322
381
Deferred Taxes
3
3
5
2
-
Total Liabilities
29
23
591
579
583
Common Equity (Total)
871
894
928
553
591
Total Shareholders' Equity
871
894
928
553
591
Total Equity
871
894
928
553
762
Liabilities & Shareholders' Equity
917
944
1,550
1,166
1,377
Accumulated Minority Interest
-
-
-
-
170
Non-Equity Reserves
17
27
32
34
33

About Hainan Shuangcheng Pharmaceuticals Co.

View Profile
Address
No. 16 Xingguo Road
Haikou Hainan 570314
China
Employees -
Website http://www.shuangchengmed.com
Updated 07/08/2019
Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in the manufacture and sale of chemically synthesized peptide drugs & APIs. It offers finished dosages and generic peptide active pharmaceutical ingredient. Its products include Thymalfasin, Levocarnitine, Clindamycin Hydrochloride, Thymopentin, Famotidine and Somatostatin for Injection.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.